You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Therapy for gastrointestinal disorders

    SBC: AGENNIX, INC.            Topic: N/A

    DESCRIPTION (Applicant's Abstract): The overall goal of this research proposal is to determine the effectiveness of recombinant human lactoferrin (rhLF) for treating gastrointestinal (GI) disorders. This Phase II proposal will focus on the ability of rhLF to treat the 01 side effects of non-steroidal anti-inflammatory drugs (NSAIDs), a class of drugs widely-us ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. Therapy for gastrointestinal disorders

    SBC: AGENNIX, INC.            Topic: N/A

    DESCRIPTION (Applicant's Abstract): The overall goal of this research proposal is to determine the effectiveness of recombinant human lactoferrin (rhLF) for treating gastrointestinal (GI) disorders. This Phase II proposal will focus on the ability of rhLF to treat the 01 side effects of non-steroidal anti-inflammatory drugs (NSAIDs), a class of drugs widely-us ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  3. BROAD SPECTRUM BETA-LACTAMASE INHIBITORS

    SBC: ALAMX, LLC            Topic: N/A

    DESCRIPTION (Adapted from the application): Penicillin-resistant bacteria pose a serious threat to human welfare. This project will generate new products designed to defeat resistant microorganisms. The most prevalent cause of bacterial resistance involves the destruction of the antibiotic with the enzyme B-lactamase. There are more than 255 known B-lactamases, whi ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. A P. falciparum MSP1 p42/QS-21 malaria vaccine

    SBC: Agenus Inc.            Topic: N/A

    DESCRIPTION: (Adapted from Applicant's Abstract) Malaria is a disease which affects more than 300 million people each year and is fatal for 1.5 million. The overall objective of this STTR Phase I project is to produce a cGMP malaria vaccine consisting of the 42 kDa C-terminal polypeptide of P. falciparum merozoite surface protein-1 (MSP1.42) to be formulated with ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  5. Real Tme Intelligent Coaching for Command and Control

    SBC: APTIMA INC            Topic: N/A

    INTACT is an embedded tool to reduce operator workload un ccomples, information-rich, multi-task operational envbironments as well as an embedded coach for simulation based training. The coach is intended to ensure that a student is able to completesimulated mission task correctly, even when unsupervised during extracurtricular practice sessions.

    STTR Phase I 2001 Department of DefenseAir Force
  6. Real Tme Intelligent Coaching for Command and Control

    SBC: APTIMA INC            Topic: N/A

    INTACT is an embedded tool to reduce operator workload un ccomples, information-rich, multi-task operational envbironments as well as an embedded coach for simulation based training. The coach is intended to ensure that a student is able to completesimulated mission task correctly, even when unsupervised during extracurtricular practice sessions.

    STTR Phase II 2001 Department of DefenseAir Force
  7. Automated Method for Measurement of Hearing Sensitivity

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant) Every year millions of hearing tests are conducted in the U.S. for a variety of reasons, including diagnosis of ear disease, evaluation of communicative function, monitoring effects of noise and ototoxic medications. prospective research studies, and fitting of hearing aids. Although there is a "standard" hearing test method, th ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  8. Drug Delivery System for Superficial Mycoses

    SBC: Biomedical Development Corporation            Topic: N/A

    DESCRIPTION (Provided by the applicant): The goal of this project is to establish the safety and efficacy of a unique drug delivery system for use as a sustained-release, antifungal skin preparation for the treatment of superficial mycoses. The lifetime risk of acquiring a superficial mycotic infection is estimated to be between 10 and 20 percent. In the U.S., annu ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  9. Drug Delivery System for Superficial Mycoses

    SBC: Biomedical Development Corporation            Topic: N/A

    DESCRIPTION (Provided by the applicant): The goal of this project is to establish the safety and efficacy of a unique drug delivery system for use as a sustained-release, antifungal skin preparation for the treatment of superficial mycoses. The lifetime risk of acquiring a superficial mycotic infection is estimated to be between 10 and 20 percent. In the U.S., annu ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  10. Neuroprotective Drugs for Spinal Cord Injury

    SBC: Biostream Therapeutics, Inc.            Topic: N/A

    DESCRIPTION: (Adapted from the Applicant's Abstract) Traumatic spinal cord injury (SCI) leads to permanent loss of motor function and control of function below the level of the injury. A significant portion of the loss is due to secondary factors rather than the initial trauma. These factors include increased extracellular concentrations of glutamate which ha ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government